Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2025-12-24 @ 11:30 PM
NCT ID: NCT02636556
Eligibility Criteria: Inclusion Criteria: 1.18\~75 years old; 2.Eastern Cooperative Oncology Group performance status of 0 to 2; 3.Pathologically or cytologically confirmed untreated thymoma or thymic carcinoma; 4.Unresectable, limited adanced disease could be encompassed within a tolerable radiotherapy field; 5.Have adequate bone marrow, hepatic, and renal function; 6.Patients who cannot receive surgery resection; 7.Written informed consent. Exclusion Criteria: 1. Distant metastases could not be encompassed within a tolerable radiotherapy field; 2. Underwent surgery, radiotherapy or chemotherapy before entering this study ; 3. Have other malignancy history excluding carcinoma in situ of cervix in the previous five years; 4. Active clinical pulmonary infection; 5. Pregnant or nursing.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 75 Years
Study: NCT02636556
Study Brief:
Protocol Section: NCT02636556